-- 儘管美伊緊張局勢持續，且美國封鎖霍爾木茲海峽的關鍵問題仍未找到最終解決方案，伊朗總統馬蘇德·佩澤什基安也向巴基斯坦總理謝赫巴茲·謝里夫表示，德黑蘭不會在圍困、威脅或壓力下與美國進行談判，但韓國股市週一開盤走高。 韓國綜合股價指數（KOSPI）上漲0.9%，即57.97點，開盤報6533.60點。韓國創業板指數（KOSDAQ）上漲9.29點，開盤報1213.13點。 在地區緊張局勢加劇之際，伊朗外長阿巴斯·阿拉格奇將於週一在莫斯科會見俄羅斯總統弗拉基米爾·普京，預計會談將聚焦美伊停火、地區緊張局勢以及涉及美國和以色列的更廣泛談判。 俄羅斯駐維也納國際組織代表米哈伊爾·烏裡揚諾夫週一表示，如果美國想要與伊朗的談判取得進展，就必須放棄「謳詐」和「最後通牒」。 週一早盤交易中，三星電子（KRX:005930）和SK海力士（KRX:000660）股價分別上漲1.82%和5.24%。
Related Articles
Asia
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
$HKG:0895$SHE:002672
Sectors
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.
$HKG:6866